1. Home
  2. CNEY vs INTS Comparison

CNEY vs INTS Comparison

Compare CNEY & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNEY
  • INTS
  • Stock Information
  • Founded
  • CNEY 2018
  • INTS 2012
  • Country
  • CNEY China
  • INTS United States
  • Employees
  • CNEY N/A
  • INTS N/A
  • Industry
  • CNEY Major Chemicals
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNEY Industrials
  • INTS Health Care
  • Exchange
  • CNEY Nasdaq
  • INTS Nasdaq
  • Market Cap
  • CNEY 8.0M
  • INTS 8.4M
  • IPO Year
  • CNEY 2021
  • INTS 2023
  • Fundamental
  • Price
  • CNEY $2.27
  • INTS $0.30
  • Analyst Decision
  • CNEY
  • INTS Strong Buy
  • Analyst Count
  • CNEY 0
  • INTS 4
  • Target Price
  • CNEY N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • CNEY 10.4K
  • INTS 5.8M
  • Earning Date
  • CNEY 01-01-0001
  • INTS 08-07-2025
  • Dividend Yield
  • CNEY N/A
  • INTS N/A
  • EPS Growth
  • CNEY N/A
  • INTS N/A
  • EPS
  • CNEY N/A
  • INTS N/A
  • Revenue
  • CNEY $50,957,974.00
  • INTS N/A
  • Revenue This Year
  • CNEY N/A
  • INTS N/A
  • Revenue Next Year
  • CNEY N/A
  • INTS N/A
  • P/E Ratio
  • CNEY N/A
  • INTS N/A
  • Revenue Growth
  • CNEY N/A
  • INTS N/A
  • 52 Week Low
  • CNEY $1.97
  • INTS $0.19
  • 52 Week High
  • CNEY $40.00
  • INTS $4.35
  • Technical
  • Relative Strength Index (RSI)
  • CNEY 46.93
  • INTS 49.95
  • Support Level
  • CNEY $2.06
  • INTS $0.28
  • Resistance Level
  • CNEY $2.32
  • INTS $0.32
  • Average True Range (ATR)
  • CNEY 0.12
  • INTS 0.03
  • MACD
  • CNEY 0.02
  • INTS 0.01
  • Stochastic Oscillator
  • CNEY 73.42
  • INTS 78.80

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: